Primary record
2-Propenoic acid, 3-(1-((5-(1-fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl)carbonyl)-3-methyl-1H-indol-4-yl)-, (2E)-
- 库存
- 3,880 克
- 纯度
- 99.0 %
- CAS
- 1898206-17-1
化合物标识与属性
- CAS
- 1898206-17-1
- PubChem CID
- 130306983
- SMILES
- CC1=CN(C2=CC=CC(=C12)/C=C/C(=O)O)C(=O)C3=C(ON=C3C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)F
- Canonical SMILES
- Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12
名称与同义词
- Safusidenib
- Safusidenib [INN]
- RCK8KK7SB9
- AB-291 free acid
- DS-1001 free acid
- UNII-RCK8KK7SB9
- Safusidenib [WHO-DD]
- DS-1001b
- RefChem:180830
- orb1686259
- CHEMBL4651002
- SCHEMBL19216573
- SCHEMBL29648127
- GTPL11884
- AB218
- BDBM278559
- BDBM278589
- GLXC-27904
- DS-1001
- US10040791, Example 21
- US10040791, Example 51
- 1898206-17-1
- AB 218
- AB-218
- DS 1001
- DA-67375
- HY-145594
- CS-0376579
- (E)-3-(1-(5-(2-Fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)isoxazole-4-carbonyl)-3-methyl-1H-indol-4-yl)acrylic acid
- Mutant Isocitrate Dehydrogenase Type 1 Inhibitor DS-1001
- (E)-3-(1-(5-(1-Fluoro-1-methyl-ethyl)-3-(2,4,6-trichlorophenyl)isoxazole-4-carbonyl)-3-methyl-indol-4-yl)prop-2-enoic acid
- (E)-3-[1-[5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazole-4-carbonyl]-3-methylindol-4-yl]prop-2-enoic acid
- 1898207-64-1
- 2-Propenoic acid, 3-(1-((5-(1-fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl)carbonyl)-3-methyl-1H-indol-4-yl)-, (2E)-
- (2E)-3-(1-{[5-(1,1- Difluoroethyl)-3-(2,4,6- trichlorophenyl)-1,2-oxazol-4- yl]carbonyl}-3-methyl-1H- indol-4-yl)prop-2-enoic acid
- (2E)-3-(1-{[5-(2-Fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazol-4-yl]carbonyl}-3-methyl-1H-indol-4-yl)prop-2-enoic acid
- (2E)-3-[1-[[5-(1-Fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl]carbonyl]-3-methyl-1H-indol-4-yl]-2-propenoic acid
- (2E)-3-{1-[5-(2-Fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazole-4-carbonyl]-3-methyl-1H-indol-4-yl}prop-2-enoic acid
- (E)-3-(1-(5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazole-4-carbonyl)-3-methylindol-4-yl)prop-2-enoic acid
- 2-Propenoic acid, 3-[1-[[5-(1-fluoro-1-methylethyl)-3-(2,4,6-trichlorophenyl)-4-isoxazolyl]carbonyl]-3-methyl-1H-indol-4-yl]-, (2E)-
- 7SU